171 related articles for article (PubMed ID: 24618035)
1. Lymphocytes from chronic lymphocytic leukaemia undergo ABL1-linked amoeboid motility and homotypic interaction as an early adaptive change to ex vivo culture.
Hutchinson CV; Natarajan S; Johnson SM; Adams JA; Rees-Unwin KS; Burthem J
Exp Hematol Oncol; 2014 Mar; 3(1):7. PubMed ID: 24618035
[TBL] [Abstract][Full Text] [Related]
2. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
Brown S; Hutchinson CV; Aspinall-O'Dea M; Whetton AD; Johnson SM; Rees-Unwin K; Burthem J
Eur J Haematol; 2014 Aug; 93(2):96-102. PubMed ID: 24617663
[TBL] [Abstract][Full Text] [Related]
3. Homotypic interactions protect chronic lymphocytic leukaemia cells from spontaneous death in vitro.
Pettitt AR; Moran EC; Cawley JC
Leuk Res; 2001 Nov; 25(11):1003-12. PubMed ID: 11597735
[TBL] [Abstract][Full Text] [Related]
4. Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells.
Hamilton E; Pearce L; Morgan L; Robinson S; Ware V; Brennan P; Thomas NS; Yallop D; Devereux S; Fegan C; Buggins AG; Pepper C
Br J Haematol; 2012 Sep; 158(5):589-99. PubMed ID: 22712573
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome
Wurzer H; Filali L; Hoffmann C; Krecke M; Biolato AM; Mastio J; De Wilde S; François JH; Largeot A; Berchem G; Paggetti J; Moussay E; Thomas C
Front Immunol; 2021; 12():619069. PubMed ID: 34108958
[TBL] [Abstract][Full Text] [Related]
6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
7. Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Viswanathan K; Roboz G; Chadburn A; Mathew S
Int J Surg Pathol; 2020 Apr; 28(2):216-224. PubMed ID: 31544558
[TBL] [Abstract][Full Text] [Related]
8. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
Filip AA; Ciseł B; Wąsik-Szczepanek E
Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
[TBL] [Abstract][Full Text] [Related]
9. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
[TBL] [Abstract][Full Text] [Related]
10. Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia.
Minici C; Gounari M; Übelhart R; Scarfò L; Dühren-von Minden M; Schneider D; Tasdogan A; Alkhatib A; Agathangelidis A; Ntoufa S; Chiorazzi N; Jumaa H; Stamatopoulos K; Ghia P; Degano M
Nat Commun; 2017 Jun; 8():15746. PubMed ID: 28598442
[TBL] [Abstract][Full Text] [Related]
11. CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro.
Burgess M; Cheung C; Chambers L; Ravindranath K; Minhas G; Knop L; Mollee P; McMillan NA; Gill D
Leuk Lymphoma; 2012 Oct; 53(10):1988-98. PubMed ID: 22397722
[TBL] [Abstract][Full Text] [Related]
12. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium.
Till KJ; Spiller DG; Harris RJ; Chen H; Zuzel M; Cawley JC
Blood; 2005 Jun; 105(12):4813-9. PubMed ID: 15731179
[TBL] [Abstract][Full Text] [Related]
13. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Busch C; Mulholland T; Zagnoni M; Dalby M; Berry C; Wheadon H
Cell Commun Signal; 2023 Nov; 21(1):342. PubMed ID: 38031192
[TBL] [Abstract][Full Text] [Related]
14. CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells.
Shcherbina V; Gordiienko I; Shlapatska L; Gluzman D; Sidorenko S
Neoplasma; 2021 Jul; 68(4):760-769. PubMed ID: 33904315
[TBL] [Abstract][Full Text] [Related]
15. How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection.
Scielzo C; Ten Hacken E; Bertilaccio MT; Muzio M; Calissano C; Ghia P; Caligaris-Cappio F
Leuk Lymphoma; 2010 Aug; 51(8):1371-4. PubMed ID: 20687794
[TBL] [Abstract][Full Text] [Related]
16. Human lymphocyte motility: normal characteristics and anomalous behavior of chronic lymphocytic leukemia cells.
Jarvis SC; Snyderman R; Cohen HJ
Blood; 1976 Nov; 48(5):717-29. PubMed ID: 1086108
[TBL] [Abstract][Full Text] [Related]
17. Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
Ten Hacken E; Sivina M; Kim E; O'Brien S; Wierda WG; Ferrajoli A; Estrov Z; Keating MJ; Oellerich T; Scielzo C; Ghia P; Caligaris-Cappio F; Burger JA
J Immunol; 2016 Sep; 197(6):2522-31. PubMed ID: 27534555
[TBL] [Abstract][Full Text] [Related]
18. Septins provide microenvironment sensing and cortical actomyosin partitioning in motile amoeboid T lymphocytes.
Zhovmer AS; Manning A; Smith C; Nguyen A; Prince O; Sáez PJ; Ma X; Tsygankov D; Cartagena-Rivera AX; Singh NA; Singh RK; Tabdanov ED
Sci Adv; 2024 Jan; 10(1):eadi1788. PubMed ID: 38170778
[TBL] [Abstract][Full Text] [Related]
19. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
Till KJ; Pettitt AR; Slupsky JR
J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
[TBL] [Abstract][Full Text] [Related]
20. T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation.
Imbery JF; Heinzelbecker J; Jebsen JK; McGowan M; Myklebust C; Bottini N; Stanford SM; Skånland SS; Tveita A; Tjønnfjord GE; Munthe LA; Szodoray P; Nakken B
Br J Haematol; 2022 Aug; 198(3):556-573. PubMed ID: 35655388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
